The Use of Intraperitoneal Ropivacaine in Bariatric Bypass Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a pilot study in a randomized, controlled, double-blinded format and will evaluate the ability of a local anesthetic, Ropivacaine, to decrease pain after gastric bypass surgery. The drug will be administered into the abdomen during a bariatric bypass surgery. After surgery, patients who received Ropivacaine will be compared to those without Ropivacaine to determine its effect on reducing pain, recovery of lung function, ability to walk, and quality of life during recovery.
Epistemonikos ID: 2e655cb9be637bce05aadd9e151019814f8193c6
First added on: May 11, 2024